Historical record - last NADAC effective date: 2/18/2015
Product Information
QC FIBERLAX 625 MG CAPLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0525 per EA under NDC 63868053090. Its NADAC has been published 67 times since Nov 28, 2013.
The Low Outlier badge above means this manufacturer's average price in the Calcium Polycarbophil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
625 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868053090
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2015
Active Ingredients
CALCIUM POLYCARBOPHILApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
4/16/2019
Price Statistics
The NADAC for QC FIBERLAX 625 MG CAPLET has been published 67 times since Nov 28, 2013, and over the history we have for it it has declined 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0525 per EA |
|---|---|
| All-time high | $0.0613 (Sep 10, 2014) |
| All-time low | $0.0525 (Feb 18, 2015) |
| Median price | $0.0566 |
| Average price | $0.0567 |
| Largest weekly change | -7.2% (Feb 18, 2015) |
| Weeks tracked | 67 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-3.0%
Last surveyed Mar 4, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcium Polycarbophil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC FIBERLAX 625 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for QC FIBERLAX 625 MG CAPLET, manufactured by Chain Drug Marketing Association, is $0.0525 per EA (NDC 63868053090), effective Mar 4, 2015.
How has the price of QC FIBERLAX 625 MG CAPLET changed over time?
Over the history we have for it, the NADAC for QC FIBERLAX 625 MG CAPLET has declined 3.0%. It has been tracked across 67 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QC FIBERLAX 625 MG CAPLET?
Since Nov 28, 2013, the NADAC for QC FIBERLAX 625 MG CAPLET has ranged from a low of $0.0525 (Feb 18, 2015) to a high of $0.0613 (Sep 10, 2014), with a median of $0.0566 per EA.
Are there cheaper alternatives to QC FIBERLAX 625 MG CAPLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC FIBERLAX 625 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures QC FIBERLAX 625 MG CAPLET?
QC FIBERLAX 625 MG CAPLET (NDC 63868053090) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.